Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Imunon, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 18 | 18 | 0 |
| Shares | 335.5K | 372.9K | +37.4K (+11.1%) |
| Value | $539.4K | $442.0K | −$97.4K (−18.1%) |
New holders (3)
Institutions that held Imunon, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 77 | $89 | 0.00% |
| Caitlin John, LLC | 19 | $22 | 0.00% |
| Allworth Financial LP | 2 | $3 | 0.00% |
Sold out (3)
Institutions that held Imunon, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| FMR LLC | 145 | $238 |
| Wells Fargo & Company | 73 | $120 |
| Citigroup Inc | 46 | $75 |